NCT06789497View on ClinicalTrials.gov

The GABAergic Inhibitory System in Drug Resistant Epilepsy

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 12, 2020

Primary Completion Date

January 1, 2024

Study Completion Date

April 1, 2024

Conditions
Drug Resistant EpilepsyTemporal Lobe Epilepsy
Interventions
DRUG

Lovastatin 60 MG

Participants were given lovastatin 60 mg/day for three consecutive days.

DRUG

Placebo

Participants were given placebo 60 mg/day for three consecutive days.

Trial Locations (1)

3000-548

Institute of Nuclear Sciences Applied to Health, Coimbra

All Listed Sponsors
lead

University of Coimbra

OTHER

NCT06789497 - The GABAergic Inhibitory System in Drug Resistant Epilepsy | Biotech Hunter | Biotech Hunter